Bank Ganesha Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Ganesha Tbk trades at Rp110 (market cap 2.59T, 543.6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank Ganesha Tbk is far larger — about 15.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Ganesha Tbk is more actively traded (543.6K versus 214.9K). Which is the better fit depends on your goals.
| BGTG | OBAT | |
|---|---|---|
Market Cap | 2.59T | 164.65B |
Volume | 543.6K | 214.9K |
Lot | 5.44K | 2.15K |
Turnover | 59.52M | 51.97M |
Average Price | 109.49 | 241.85 |
Value | 59.52M | 51.97M |
Indicative Equilibrium Price | 110 | 240 |
Indicative Equilibrium Volume | 87 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
P.T. Bank Ganesha Tbk (”the Bank”) was established based on Deed No. 47 dated May 15, 1990 of notary Esther Daniar Iskandar S.H. The Bank started commercial operations on April 30, 1992 when it obtained its business license based on the Decision Letter No. 393/KMK-013/1992 dated April 14, 1992 from the Minister of Finance of the Republic of Indonesia. In accordance with Bank Indonesia’sDecision Letter No. 26/66/KEP/DIR dated September 12, 1995, the Bank is authorized to be a foreign exchange bank.
Read more on BGTG →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →